CC(=O)OC1CC[C@]2(C)C(CC[C@@]3(C)C2C(=O)C=C2C4C(C)C(C)CC[C@@]4(C(=O)O)CCC23C)C1(C)C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?